Finke, D.; Heckmann, M.B.; Salatzki, J.; Riffel, J.; Herpel, E.; Heinzerling, L.M.; Meder, B.; Völkers, M.; Müller, O.J.; Frey, N.;
et al. Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation. Cancers 2021, 13, 2498.
https://doi.org/10.3390/cancers13102498
AMA Style
Finke D, Heckmann MB, Salatzki J, Riffel J, Herpel E, Heinzerling LM, Meder B, Völkers M, Müller OJ, Frey N,
et al. Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation. Cancers. 2021; 13(10):2498.
https://doi.org/10.3390/cancers13102498
Chicago/Turabian Style
Finke, Daniel, Markus B. Heckmann, Janek Salatzki, Johannes Riffel, Esther Herpel, Lucie M. Heinzerling, Benjamin Meder, Mirko Völkers, Oliver J. Müller, Norbert Frey,
and et al. 2021. "Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation" Cancers 13, no. 10: 2498.
https://doi.org/10.3390/cancers13102498
APA Style
Finke, D., Heckmann, M. B., Salatzki, J., Riffel, J., Herpel, E., Heinzerling, L. M., Meder, B., Völkers, M., Müller, O. J., Frey, N., Katus, H. A., Leuschner, F., Kaya, Z., & Lehmann, L. H.
(2021). Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation. Cancers, 13(10), 2498.
https://doi.org/10.3390/cancers13102498